Cost-effectiveness of axicabtagene ciloleucel as second-line therapy for patients large B-cell lymphoma (LBCL) in the United States Meeting Abstract


Authors: Perales, M. A.; Kuruvilla, J.; Snider, J. T.; Vadgama, S.; Blissett, R.; El-Moustaid, F.; Smith, N.; Patel, A.; Johnston, P.
Abstract Title: Cost-effectiveness of axicabtagene ciloleucel as second-line therapy for patients large B-cell lymphoma (LBCL) in the United States
Meeting Title: 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)
Journal Title: Bone Marrow Transplantation
Volume: 57
Issue: Suppl. 1
Meeting Dates: 2022 Mar 19-23
Meeting Location: Virtual
ISSN: 0268-3369
Publisher: Nature Publishing Group  
Date Published: 2022-11-02
Start Page: 130
End Page: 131
Language: English
ACCESSION: WOS:000878153300196
PROVIDER: wos
PMCID: PMC9628617
PUBMED: 36323940
DOI: 10.1038/s41409-022-01798-0
Notes: Meeting Abstract: P056 -- located in section, "Poster Session (P001 - P578)" -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Miguel-Angel Perales
    914 Perales